Correlation Between Elcom Technology and Daklak Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Elcom Technology and Daklak Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elcom Technology and Daklak Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Elcom Technology Communications and Daklak Pharmaceutical Medical, you can compare the effects of market volatilities on Elcom Technology and Daklak Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elcom Technology with a short position of Daklak Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elcom Technology and Daklak Pharmaceutical.

Diversification Opportunities for Elcom Technology and Daklak Pharmaceutical

0.0

Correlation Coefficient

Elcom Technology  Daklak Pharmaceutical

Pay attention - limited upside

The 3 months correlation between Elcom and Daklak is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Elcom Technology Communication and Daklak Pharmaceutical Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Daklak Pharmaceutical and Elcom Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elcom Technology Communications are associated (or correlated) with Daklak Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Daklak Pharmaceutical has no effect on the direction of Elcom Technology i.e., Elcom Technology and Daklak Pharmaceutical go up and down completely randomly.

Pair Corralation between Elcom Technology and Daklak Pharmaceutical

If you would invest  2,445,000  in Elcom Technology Communications on September 26, 2024 and sell it today you would earn a total of  345,000  from holding Elcom Technology Communications or generate 14.11% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Elcom Technology Communication  vs.  Daklak Pharmaceutical Medical

Elcom Technology Com

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Elcom Technology Communications are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, Elcom Technology displayed solid returns over the last few months and may actually be approaching a breakup point.

Daklak Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Daklak Pharmaceutical Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental drivers, Daklak Pharmaceutical is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Elcom Technology and Daklak Pharmaceutical

The main advantage of trading using opposite Elcom Technology and Daklak Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elcom Technology position performs unexpectedly, Daklak Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Daklak Pharmaceutical will offset losses from the drop in Daklak Pharmaceutical's long position.

The idea behind Elcom Technology Communications and Daklak Pharmaceutical Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.